Sign in

CIK 0002028614 · <br>Emerging growth company

Drugs Made In America Acquisition Corp.

Sign in to watch
Ticker
DMAA
Exchange
Nasdaq
Industry
Blank Checks
FY end
Dec 31
Entity type
operating
Phone
646-726-7074
Business address
420 LEXINGTON AVENUE, SUITE 1402, NEW YORK, NY, 10170

Securities

  • DMAA Ordinary Shares Nasdaq
  • DMAAR Rights Nasdaq
  • DMAAU Units Nasdaq
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. CERT Other Certification
  8. EFFECT Other Notice of Effectiveness
  9. 8-A12B Other Registration of Securities
  10. S-1/A Offering Registration Statement
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. S-1/A Offering Registration Statement
  14. S-1/A Offering Registration Statement
  15. S-1/A Offering Registration Statement
  16. S-1/A Offering Registration Statement
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. S-1/A Offering Registration Statement
  19. UPLOAD Other SEC-generated Letter
  20. S-1 Offering Registration Statement

Page 4 of 4 · 80 filings